Initiation of lytic DNA replication in Epstein-Barr virus: Search for a common family mechanism

Future Virology

Volumn 5, Issue 1, 2010, Pages 65-83

  Rennekamp, Andrew J ^a,b   Lieberman, Paul M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

BZLF1; EBV; Epstein Barr; OriLyt; Recombination; Repair; Replication; Zta

Indexed keywords

ATM PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA BINDING PROTEIN; DNA POLYMERASE; DOUBLE STRANDED DNA; EXONUCLEASE; HELICASE; IMMEDIATE EARLY PROTEIN BZLF1; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LEUCINE ZIPPER PROTEIN; MRE11 PROTEIN; NIBRIN; PROTEIN P53; RAD50 PROTEIN; SINGLE STRANDED DNA; URACIL DNA GLYCOSIDASE; VIRUS DNA; VIRUS NUCLEOPROTEIN;

BURKITT LYMPHOMA; DNA DAMAGE; DNA REPLICATION; EPSTEIN BARR VIRUS; GENETIC CONSERVATION; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; INFECTIOUS MONONUCLEOSIS; KAPOSI SARCOMA; LEUKOPLAKIA; LYMPHOPROLIFERATIVE DISEASE; MEDICAL LITERATURE; NASOPHARYNX CARCINOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; VIROGENESIS; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 74049158642     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.09.69     Document Type: Review

References (266)

1. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4(10), 757-768 (2004).
2. Schulz TF: The pleiotropic effects of Kaposi's sarcoma herpesvirus. J. Pathol. 208(2), 187-198 (2006).
3. Joab I, Nicolas JC, Schwaab G et al.: Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer 48(5), 647-649 (1991). ■ Implicates Epstein-Barr virus (EBV) lytic-cycle gene products as a causative agent in the formation of nasopharyngeal carcinoma.
4. Feng WH, Cohen JI, Fischer S et al.: Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J. Natl Cancer Inst. 96(22), 1691-1702 (2004). ■ Implicates EBV lytic cycle as a causative agent in the formation of lymphomas in rheumatiod arthritis and poliomyositis patients treated with methotrexate.
5. Moormann AM, Chelimo K, Sumba OP et al.: Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J. Infect. Dis. 191(8), 1233-1238 (2005).
6. Chene A, Donati D, Guerreiro-Cacais AO et al.: A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog. 3(6), e80 (2007). ■ The plasmodium falciparum 1 membrane protein is able to induce lytic EBV.
7. Billaud G, Thouvenot D, Morfin F: Drug targets in herpes simplex and Epstein-Barr virus infections. Infect. Disord. Drug Targets 9(2), 117-125 (2009).
8. Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ, Pari GS: A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79(6), 3479-3487 (2005).
9. Feederle R, Kost M, Baumann M et al.: The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19(12), 3080-3089 (2000). ■ Classical genetic study where the BRLF1 or BZLF1 genes were knocked out in the context of the full viral genome.
10. Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A: Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5(12), 3243-3249 (1986).
11. Countryman J, Miller G: Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl Acad. Sci. USA 82(12), 4085-4089 (1985).
12. Rooney CM, Rowe DT, Ragot T, Farrell PJ: The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J. Virol. 63(7), 3109-3116 (1989).
13. Takada K, Shimizu N, Sakuma S, Ono Y: trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J. Virol. 57(3), 1016-1022 (1986).
14. Polson AG, Huang L, Lukac DM et al.: Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol. 75(7), 3175-3184 (2001).
15. Kato-Noah T, Xu Y, Rossetto CC, Colletti K, Papouskova I, Pari GS: Overexpression of the Kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype. J. Virol. 81(24), 13519-13532 (2007).
16. Hong GK, Gulley ML, Feng WH, Delecluse HJ, Holley-Guthrie E, Kenney SC: Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J. Virol. 79(22), 13993-14003 (2005). ■■ Demonstrates the importance of lytic replication and, specifically, the BZLF1 gene in EBV-induced tumorigenesis.
17. Hong GK, Kumar P, Wang L et al.: Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J. Virol. 79(22), 13984-13992 (2005).
18. Miyazaki I, Cheung RK, Dosch HM: Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 178(2), 439-447 (1993).
19. Stuart AD, Stewart JP, Arrand JR, Mackett M: The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11(9), 1711-1719 (1995).
20. Rousset F, Garcia E, Defrance T et al.: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl Acad. Sci. USA 89(5), 1890-1893 (1992).
21. Manet E, Gruffat H, Trescol-Biemont MC et al.: Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators. EMBO J. 8(6), 1819-1826 (1989).
22. Seaman WT, Ye D, Wang RX, Hale EE, Weisse M, Quinlivan EB: Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263(2), 436-449 (1999).
23. Amon W, Farrell PJ: Reactivation of Epstein-Barr virus from latency. Rev. Med. Virol. 15(3), 149-156 (2005).
24. Speck SH, Chatila T, Flemington E: Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5(10), 399-405 (1997).
25. Kenney SC: Reactivation and lytic replication of EBV. In: Human Herpesviruses. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, NY, USA, 403-433 (2007).
26. Challberg MD: A method for identifying the viral genes required for herpesvirus DNA replication. Proc. Natl Acad. Sci. USA 83(23), 9094-9098 (1986). ■■ Landmark study that identified the herpesvirus core lytic replication proteins using complementation assays and a plasmid containing the lytic origin.
27. Fixman ED, Hayward GS, Hayward SD: trans-acting requirements for replication of Epstein-Barr virus Ori-Lyt. J. Virol. 66(8), 5030-5039 (1992). ■ Identification of the core replication proteins required for lytic EBV replication.
28. Pari GS, Kacica MA, Anders DG: Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus OriLyt-dependent DNA synthesis. J. Virol. 67(5), 2575-2582 (1993).
29. Pari GS, Anders DG: Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus OriLyt-dependent DNA replication. J. Virol. 67(12), 6979-6988 (1993).
30. Wu FY, Ahn JH, Alcendor DJ et al.: Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J. Virol. 75(3), 1487-1506 (2001).
31. Tsurumi T: Primer terminus recognition and highly processive replication by Epstein-Barr virus DNA polymerase. Biochem. J. 280(Pt 3), 703-708 (1991).
32. Tsurumi T: Characterization of 3′-to 5′-exonuclease activity associated with Epstein-Barr virus DNA polymerase. Virology 182(1), 376-381 (1991).
33. Fujii K, Yokoyama N, Kiyono T et al.: The Epstein-Barr virus pol catalytic subunit physically interacts with the BBLF4-BSLF1- BBLF2/3 complex. J. Virol. 74(6), 2550-2557 (2000).
34. Yokoyama N, Fujii K, Hirata M et al.: Assembly of the Epstein-Barr virus BBLF4, BSLF1 and BBLF2/3 proteins and their interactive properties. J. Gen. Virol. 80(Pt 11), 2879-2887 (1999).
35. Kiehl A, Dorsky DI: Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. Virology 184(1), 330-340 (1991).
36. Li JS, Zhou BS, Dutschman GE, Grill SP, Tan RS, Cheng YC: Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J. Virol. 61(9), 2947-2949 (1987).
37. Neuhierl B, Delecluse HJ: The Epstein-Barr virus BMRF1 gene is essential for lytic virus replication. J. Virol. 80(10), 5078-5081 (2006).
38. Zhang Q, Holley-Guthrie E, Ge JQ, Dorsky D, Kenney S: The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV OriLyt. Virology 230(1), 22-34 (1997).
39. Nakayama S, Murata T, Murayama K et al.: Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein. J. Biol. Chem. 284, 21557-21568 (2009).
40. Falkenberg M, Lehman IR, Elias P: Leading and lagging strand DNA synthesis in vitro by a reconstituted herpes simplex virus type 1 replisome. Proc. Natl Acad. Sci. USA 97(8), 3896-3900 (2000).
41. Rabkin SD, Hanlon B: Herpes simplex virus DNA synthesis at a preformed replication fork in vitro. J. Virol. 64(10), 4957-4967 (1990).
42. Stow ND, Davison AJ: Identification of a varicella-zoster virus origin of DNA replication and its activation by herpes simplex virus type 1 gene products. J. Gen. Virol. 67(Pt 8), 1613-1623 (1986).
43. Sarisky RT, Hayward GS: Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting OriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J. Virol. 70(11), 7398-7413 (1996).
44. Ryon JJ, Fixman ED, Houchens C et al.: The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus Ori-Lyt: evolutionary conservation of transcriptional activation and replication signals. J. Virol. 67(7), 4006-4016 (1993).
45. Stracker TH, Cassell GD, Ward P et al.: The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication. J. Virol. 78(1), 441-453 (2004).
46. Glauser DL, Strasser R, Laimbacher AS et al.: Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. J. Virol. 81(9), 4732-4743 (2007).
47. Matz B: Herpes simplex virus infection generates large tandemly reiterated simian virus 40 DNA molecules in a transformed hamster cell line. J. Virol. 61(5), 1427-1434 (1987).
48. Elias P, O'Donnell ME, Mocarski ES, Lehman IR: A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc. Natl Acad. Sci. USA 83(17), 6322-6326 (1986). ■ Describes a study that led to the identification of UL9 as the herpes simplex virus (HSV) origin-binding protein.
49. Olivo PD, Nelson NJ, Challberg MD: Herpes simplex virus DNA replication: the UL9 gene encodes an origin-binding protein. Proc. Natl Acad. Sci. USA 85(15), 5414-5418 (1988). ■ Describes a study that led to the identification of UL9 as the herpes simplex virus (HSV) origin-binding protein.
50. Bruckner RC, Crute JJ, Dodson MS, Lehman IR: The herpes simplex virus 1 origin binding protein: a DNA helicase. J. Biol. Chem. 266(4), 2669-2674 (1991).
51. Fierer DS, Challberg MD: Purification and characterization of UL9, the herpes simplex virus type 1 origin-binding protein. J. Virol. 66(7), 3986-3995 (1992).
52. Gustafsson CM, Hammarsten O, Falkenberg M, Elias P: Herpes simplex virus DNA replication: a spacer sequence directs the ATP-dependent formation of a nucleoprotein complex at OriS. Proc. Natl Acad. Sci. USA 91(11), 4629-4633 (1994).
53. Koff A, Schwedes JF, Tegtmeyer P: Herpes simplex virus origin-binding protein (UL9) loops and distorts the viral replication origin. J. Virol. 65(6), 3284-3292 (1991).
54. Makhov AM, Boehmer PE, Lehman IR, Griffith JD: The herpes simplex virus type 1 origin-binding protein carries out origin specific DNA unwinding and forms stem-loop structures. EMBO J. 15(7), 1742-1750 (1996).
55. Makhov AM, Boehmer PE, Lehman IR, Griffith JD: Visualization of the unwinding of long DNA chains by the herpes simplex virus type 1 UL9 protein and ICP8. J. Mol. Biol. 258(5), 789-799 (1996).
56. Makhov AM, Lee SS, Lehman IR, Griffith JD: Origin-specific unwinding of herpes simplex virus 1 DNA by the viral UL9 and ICP8 proteins: visualization of a specific preunwinding complex. Proc. Natl Acad. Sci. USA 100(3), 898-903 (2003).
57. Colletti KS, Xu Y, Cei SA, Tarrant M, Pari GS: Human cytomegalovirus UL84 oligomerization and heterodimerization domains act as transdominant inhibitors of OriLyt-dependent DNA replication: evidence that IE2-UL84 and UL84-UL84 interactions are required for lytic DNA replication. J. Virol. 78(17), 9203-9214 (2004).
58. Colletti KS, Xu Y, Yamboliev I, Pari GS: Human cytomegalovirus UL84 is a phosphoprotein that exhibits UTPase activity and is a putative member of the DExD/H box family of proteins. J. Biol. Chem. 280(12), 11955-11960 (2005).
59. Colletti KS, Smallenburg KE, Xu Y, Pari GS: Human cytomegalovirus UL84 interacts with an RNA stem-loop sequence found within the RNA/DNA hybrid region of OriLyt. J. Virol. 81(13), 7077-7085 (2007). ■ Identifcation of a stem-loop RNA structure, bound by UL84, within an RNA/DNA hybrid region of cytomegalovirus OriLyt.
60. Xu Y, Cei SA, Rodriguez Huete A, Colletti KS, Pari GS: Human cytomegalovirus DNA replication requires transcriptional activation via an IE2- and UL84-responsive bidirectional promoter element within OriLyt. J. Virol. 78(21), 11664-11677 (2004).
61. Lieberman PM, Berk AJ: In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J. Virol. 64(6), 2560-2568 (1990). ■ Describes the identification of Zta as a candidate origin-binding protein for EBV.
62. Schepers A, Pich D, Hammerschmidt W: A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 12(10), 3921-3929 (1993). ■ Describes the identification of Zta as a candidate origin-binding protein for EBV.
63. Fixman ED, Hayward GS, Hayward SD: Replication of Epstein-Barr virus OriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69(5), 2998-3006 (1995). ■ Describes the identification of Zta as a candidate origin-binding protein for EBV.
64. Gao Z, Krithivas A, Finan JE et al.: The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J. Virol. 72(11), 8559-8567 (1998).
65. Liao G, Huang J, Fixman ED, Hayward SD: The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor. J. Virol. 79(1), 245-256 (2005).
66. Liao G, Wu FY, Hayward SD: Interaction with the Epstein-Barr virus helicase targets Zta to DNA replication compartments. J. Virol. 75(18), 8792-8802 (2001).
67. Zhang Q, Hong Y, Dorsky D et al.: Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication. J. Virol. 70(8), 5131-5142 (1996).
68. Chang YN, Dong DL, Hayward GS, Hayward SD: The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J. Virol. 64(7), 3358-3369 (1990).
69. Packham G, Economou A, Rooney CM, Rowe DT, Farrell PJ: Structure and function of the Epstein-Barr virus BZLF1 protein. J. Virol. 64(5), 2110-2116 (1990).
70. Farrell PJ, Rowe DT, Rooney CM, Kouzarides T: Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8(1), 127-132 (1989).
71. Urier G, Buisson M, Chambard P, Sergeant A: The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO J. 8(5), 1447-1453 (1989).
72. Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD: The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J. Virol. 64(3), 1143-1155 (1990). ■ Characterization of Zta binding sites within EBV OriLyt.
73. Flemington E, Speck SH: Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J. Virol. 64(9), 4549-4552 (1990).
74. Sato H, Takeshita H, Furukawa M, Seiki M: Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun. J. Virol. 66(8), 4732-4736 (1992).
75. Li D, Qian L, Chen C et al.: Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. J. Immunol. 182(4), 1799-1809 (2009).
76. Jones RJ, Dickerson S, Bhende PM, Delecluse HJ, Kenney SC: Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9. J. Biol. Chem. 282(11), 8317-8324 (2007).
77. Chang Y, Lee HH, Chen YT et al.: Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J. Virol. 80(15), 7748-7755 (2006).
78. Hsu M, Wu SY, Chang SS et al.: Epstein- Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J. Virol. 82(7), 3679-3688 (2008).
79. Mahot S, Sergeant A, Drouet E, Gruffat H: A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J. Gen. Virol. 84(Pt 4), 965-974 (2003).
80. Hung CH, Liu ST: Characterization of the Epstein-Barr virus BALF2 promoter. J. Gen. Virol. 80(Pt 10), 2747-2750 (1999).
81. Granato M, Farina A, Gonnella R et al.: Regulation of the expression of the Epstein- Barr virus early gene BFRF1. Virology 347(1), 109-116 (2006).
82. Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC: Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res. 21(14), 1999-2007 (1993).
83. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC: Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog. 5(3), e1000356 (2009).
84. Petosa C, Morand P, Baudin F, Moulin M, Artero JB, Muller CW: Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol. Cell 21(4), 565-572 (2006). ■■ Describes the acquisition of the first partial crystal structure of Zta.
85. Morand P, Budayova-Spano M, Perrissin M, Muller CW, Petosa C: Expression, purification, crystallization and preliminary x-ray analysis of a C-terminal fragment of the Epstein-Barr virus ZEBRA protein. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62(Pt 3), 210-214 (2006).
86. Sinclair AJ: bZIP proteins of human γ-herpesviruses. J. Gen. Virol. 84(Pt 8), 1941-1949 (2003).
87. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC: The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36(10), 1099-1104 (2004). ■ First to describe the preferential binding of Zta to methylated DNA.
88. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC: BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J. Virol. 79(12), 7338-7348 (2005).
89. Karlsson QH, Schelcher C, Verrall E, Petosa C, Sinclair AJ: Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog. 4(3), e1000005 (2008).
90. Wang Y, Tang Q, Maul GG, Yuan Y: Kaposi's sarcoma-associated herpesvirus Ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J. Virol. 80(24), 12171-12186 (2006).
91. Kagele D, Gao Y, Smallenburg K, Pari GS: Interaction of HCMV UL84 with C/EBPα transcription factor binding sites within OriLyt is essential for lytic DNA replication. Virology 392(1), 16-23 (2009).
92. Wu FY, Chen H, Wang SE et al.: CCAAT/ enhancer binding protein a interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 77(2), 1481-1500 (2003).
93. Cayrol C, Flemington E: G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J. Biol. Chem. 271(50), 31799-31802 (1996).
94. Cayrol C, Flemington EK: The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15(11), 2748-2759 (1996).
95. Rodriguez A, Armstrong M, Dwyer D, Flemington E: Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J. Virol. 73(11), 9029-9038 (1999).
96. Wu FY, Wang SE, Chen H, Wang L, Hayward SD, Hayward GS: CCAAT/ enhancer binding protein α binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle. J. Virol. 78(9), 4847-4865 (2004).
97. Flemington EK: Herpesvirus lytic replication and the cell cycle: arresting new developments. J. Virol. 75(10), 4475-4481 (2001).
98. Wu FY, Tang QQ, Chen H et al.: Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-a. Proc. Natl Acad. Sci. USA 99(16), 10683-10688 (2002). ■ First to describe a role for C/EBP-a in herpesvirus lytic replication.
99. Izumiya Y, Izumiya C, Van Geelen A et al.: Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP. J. Virol. 81(3), 1072-1082 (2007).
100. Katano H, Ogawa-Goto K, Hasegawa H, Kurata T, Sata T: Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. Virology 286(2), 446-455 (2001).
101. Wu FY, Wang SE, Tang QQ et al.: Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein α and p21(CIP-1). J. Virol. 77(16), 8893-8914 (2003).
102. Wang SE, Wu FY, Yu Y, Hayward GS: CCAAT/enhancer-binding protein-α is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J. Virol. 77(17), 9590-9612 (2003).
103. Liao W, Tang Y, Lin SF, Kung HJ, Giam CZ: K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J. Virol. 77(6), 3809-3815 (2003).
104. Rossetto C, Yamboliev I, Pari GS: Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates LANA mediated suppression of lytic origin-dependent DNA synthesis. J. Virol. 83(17), 8492-8501 (2009).
105. Lefort S, Flamand L: Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines. J. Virol. 83(11), 5869-5880 (2009).
106. Lin CL, Li H, Wang Y, Zhu FX, Kudchodkar S, Yuan Y: Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin. J. Virol. 77(10), 5578-5588 (2003).
107. Wang P, Day L, Dheekollu J, Lieberman PM: A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J. Virol. 79(21), 13298-13309 (2005).
108. Hwang S, Gwack Y, Byun H, Lim C, Choe J: The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol. 75(19), 9509-9516 (2001).
109. Al Mehairi S, Cerasoli E, Sinclair AJ: Investigation of the multimerization region of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) protein K-bZIP: the proposed leucine zipper region encodes a multimerization domain with an unusual structure. J. Virol. 79(12), 7905-7910 (2005).
110. Rossetto C, Gao Y, Yamboliev I, Papouskova I, Pari G: Transcriptional repression of K-Rta by Kaposi's sarcoma-associated herpesvirus K-bZIP is not required for OriLyt-dependent DNA replication. Virology 369(2), 340-350 (2007).
111. AuCoin DP, Colletti KS, Cei SA, Papouskova I, Tarrant M, Pari GS: Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP). Virology 318(2), 542-555 (2004).
112. Wang Y, Li H, Chan MY, Zhu FX, Lukac DM, Yuan Y: Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol. 78(16), 8615-8629 (2004).
113. Stow ND: Localization of an origin of DNA replication within the TRS/IRS repeated region of the herpes simplex virus type 1 genome. EMBO J. 1(7), 863-867 (1982). ■■ Describes identification of the first herpesvirus lytic origins.
114. Stow ND, McMonagle EC: Characterization of the TRS/IRS origin of DNA replication of herpes simplex virus type 1. Virology 130(2), 427-438 (1983). ■■ Describes identification of the first herpesvirus lytic origins.
115. Weller SK, Spadaro A, Schaffer JE, Murray AW, Maxam AM, Schaffer PA: Cloning, sequencing, and functional analysis of OriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol. Cell. Biol 5(5), 930-942 (1985). ■■ Describes identification of the first herpesvirus lytic origins.
116. Balliet JW, Min JC, Cabatingan MS, Schaffer PA: Site-directed mutagenesis of large DNA palindromes: construction and in vitro characterization of herpes simplex virus type 1 mutants containing point mutations that eliminate the OriL or OriS initiation function. J. Virol. 79(20), 12783-12797 (2005).
117. Deb S, Doelberg M: A 67-base-pair segment from the Ori-S region of herpes simplex virus type 1 encodes origin function. J. Virol. 62(7), 2516-2519 (1988).
118. Lockshon D, Galloway DA: Sequence and structural requirements of a herpes simplex viral DNA replication origin. Mol. Cell. Biol 8(10), 4018-4027 (1988). ■ Identification of the critical elements within the HSV lytic origins.
119. Koff A, Tegtmeyer P: Characterization of major recognition sequences for a herpes simplex virus type 1 origin-binding protein. J. Virol. 62(11), 4096-4103 (1988).
120. Weir HM, Stow ND: Two binding sites for the herpes simplex virus type 1 UL9 protein are required for efficient activity of the oriS replication origin. J. Gen. Virol. 71 ( Pt 6), 1379-1385 (1990).
121. Hammerschmidt W, Sugden B: Identification and characterization of OriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55(3), 427-433 (1988). ■ Describes the identification of the EBV OriLyt.
122. Schepers A, Pich D, Mankertz J, Hammerschmidt W: cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus. J. Virol. 67(7), 4237-4245 (1993). ■ Describes the identification of the EBV OriLyt.
123. Schepers A, Pich D, Hammerschmidt W: Activation of OriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220(2), 367-376 (1996).
124. Baumann M, Feederle R, Kremmer E, Hammerschmidt W: Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, OriLyt. EMBO J. 18(21), 6095-6105 (1999).
125. Gruffat H, Renner O, Pich D, Hammerschmidt W: Cellular proteins bind to the downstream component of the lytic origin of DNA replication of Epstein-Barr virus. J. Virol. 69(3), 1878-1886 (1995).
126. Portes-Sentis S, Sergeant A, Gruffat H: A particular DNA structure is required for the function of a cis-acting component of the Epstein-Barr virus OriLyt origin of replication. Nucleic Acids Res. 25(7), 1347-1354 (1997).
127. Gruffat H, Manet E, Rigolet A, Sergeant A: The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Res. 18(23), 6835-6843 (1990). ■ Characterization of Rta as a lytic origin-binding protein.
128. AuCoin DP, Colletti KS, Xu Y, Cei SA, Pari GS: Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J. Virol. 76(15), 7890-7896 (2002).
129. Lukac DM, Yuan Y: Reactivation and lytic replication of KSHV. In: Human Herpesviruses. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, NY, USA, 434-460 (2007).
130. Xu Y, Rodriguez-Huete A, Pari GS: Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome. J. Virol. 80(19), 9905-9909 (2006).
131. Gong D, Qi J, Arumugaswami V, Sun R, Deng H: Identification and functional characterization of the left origin of lytic replication of murine γ-herpesvirus 68. Virology 387(2), 285-295 (2009).
132. Deng H, Chu JT, Park NH, Sun R: Identification of cis sequences required for lytic DNA replication and packaging of murine g-herpesvirus 68. J. Virol. 78(17), 9123-9131 (2004).
133. Flach B, Steer B, Thakur NN, Haas J, Adler H: The M10 locus of murine g-herpesvirus 68 contributes to both the lytic and latent phase of infection. J. Virol. doi: 10.1128/JVI.00629-09 (2009) (Epub ahead of print).
134. Hamzeh FM, Lietman PS, Gibson W, Hayward GS: Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination. J. Virol. 64(12), 6184-6195 (1990).
135. Anders DG, Kacica MA, Pari G, Punturieri SM: Boundaries and structure of human cytomegalovirus OriLyt, a complex origin for lytic-phase DNA replication. J. Virol. 66(6), 3373-3384 (1992).
136. Borst EM, Messerle M: Analysis of human cytomegalovirus OriLyt sequence requirements in the context of the viral genome. J. Virol. 79(6), 3615-3626 (2005).
137. Zhu Y, Huang L, Anders DG: Human cytomegalovirus OriLyt sequence requirements. J. Virol. 72(6), 4989-4996 (1998).
138. Anders DG, Punturieri SM: Multicomponent origin of cytomegalovirus lytic-phase DNA replication. J. Virol. 65(2), 931-937 (1991).
139. Masse MJ, Karlin S, Schachtel GA, Mocarski ES: Human cytomegalovirus origin of DNA replication (OriLyt) resides within a highly complex repetitive region. Proc. Natl Acad. Sci. USA 89(12), 5246-5250 (1992).
140. Anders DG, Kerry JA, Pari GS: DNA synthesis and late viral gene expression. In: Human Herpesviruses. Arvin A, Campadelli-Fiume G, Mocarski, E et al. (Eds). Cambridge University Press, NY, USA, 295-310 (2007).
141. Huang L, Zhu Y, Anders DG: The variable 3μ ends of a human cytomegalovirus OriLyt transcript (SRT) overlap an essential, conserved replicator element. J. Virol. 70(8), 5272-5281 (1996).
142. Prichard MN, Jairath S, Penfold ME, St Jeor S, Bohlman MC, Pari GS: Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol. 72(9), 6997-7004 (1998).
143. Malik AK, Weller SK: Use of transdominant mutants of the origin-binding protein (UL9) of herpes simplex virus type 1 to define functional domains. J. Virol. 70(11), 7859-7866 (1996).
144. Marintcheva B, Weller SK: Residues within the conserved helicase motifs of UL9, the origin-binding protein of herpes simplex virus-1, are essential for helicase activity but not for dimerization or origin binding activity. J. Biol. Chem. 276(9), 6605-6615 (2001).
145. Marintcheva B, Weller SK: Existence of transdominant and potentiating mutants of UL9, the herpes simplex virus type 1 origin-binding protein, suggests that levels of UL9 protein may be regulated during infection. J. Virol. 77(17), 9639-9651 (2003).
146. Chattopadhyay S, Weller SK: DNA binding activity of the herpes simplex virus type 1 origin binding protein, UL9, can be modulated by sequences in the N terminus: correlation between transdominance and DNA binding. J. Virol. 80(9), 4491-4500 (2006).
147. Lee SS, Lehman IR: Unwinding of the box I element of a herpes simplex virus type 1 origin by a complex of the viral origin binding protein, single-strand DNA binding protein, and single-stranded DNA. Proc. Natl Acad. Sci. USA 94(7), 2838-2842 (1997).
148. He X, Lehman IR: Unwinding of a herpes simplex virus type 1 origin of replication (Ori(S)) by a complex of the viral origin binding protein and the single-stranded DNA binding protein. J. Virol. 74(12), 5726-5728 (2000).
149. Elias P, Gustafsson CM, Hammarsten O: The origin binding protein of herpes simplex virus 1 binds cooperatively to the viral origin of replication OriS. J. Biol. Chem. 265(28), 17167-17173 (1990).
150. Aslani A, Simonsson S, Elias P: A novel conformation of the herpes simplex virus origin of DNA replication recognized by the origin binding protein. J. Biol. Chem. 275(8), 5880-5887 (2000).
151. Macao B, Olsson M, Elias P: Functional properties of the herpes simplex virus type I origin-binding protein are controlled by precise interactions with the activated form of the origin of DNA replication. J. Biol. Chem. 279(28), 29211-29217 (2004).
152. Aslani A, Macao B, Simonsson S, Elias P: Complementary intrastrand base pairing during initiation of herpes simplex virus type 1 DNA replication. Proc. Natl Acad. Sci. USA 98(13), 7194-7199 (2001). ■ Identification of a critical DNA hairpin formed at an inverted repeat within the essential region of HSV OriLyt.
153. Aslani A, Olsson M, Elias P: ATP-dependent unwinding of a minimal origin of DNA replication by the origin-binding protein and the single-strand DNA-binding protein ICP8 from herpes simplex virus type I. J. Biol. Chem. 277(43), 41204-41212 (2002).
154. Olsson M, Tang KW, Persson C, Wilhelmsson LM, Billeter M, Elias P: Stepwise evolution of the herpes simplex virus origin binding protein and origin of replication. J. Biol. Chem. 284(24), 16246-16255 (2009).
155. Marintcheva B, Weller SK: Helicase motif Ia is involved in single-strand DNA-binding and helicase activities of the herpes simplex virus type 1 origin-binding protein, UL9. J. Virol. 77(4), 2477-2488 (2003).
156. Tsurumi T, Kobayashi A, Tamai K et al.: Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase. Virology 222(2), 352-364 (1996).
157. Quinn JP, McGeoch DJ: DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Res. 13(22), 8143-8163 (1985).
158. Mapelli M, Panjikar S, Tucker PA: The crystal structure of the herpes simplex virus 1 ssDNA-binding protein suggests the structural basis for flexible, cooperative single-stranded DNA binding. J. Biol. Chem. 280(4), 2990-2997 (2005). ■■ Crystal structure of the herpesvirus ssDNA-binding protien.
159. Mumtsidu E, Makhov AM, Konarev PV, Svergun DI, Griffith JD, Tucker PA: Structural features of the single-stranded DNA-binding protein of Epstein-Barr virus. J. Struct. Biol. 161(2), 172-187 (2008).
160. Gupte SS, Olson JW, Ruyechan WT: The major herpes simplex virus type-1 DNA-binding protein is a zinc metalloprotein. J. Biol. Chem. 266(18), 11413-11416 (1991).
161. Lee CK, Knipe DM: An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8. J. Virol. 54(3), 731-738 (1985).
162. Boehmer PE, Craigie MC, Stow ND, Lehman IR: Association of origin binding protein and single strand DNA-binding protein, ICP8, during herpes simplex virus type 1 DNA replication in vivo. J. Biol. Chem. 269(46), 29329-29334 (1994).
163. Boehmer PE, Lehman IR: Physical interaction between the herpes simplex virus 1 origin-binding protein and single-stranded DNA-binding protein ICP8. Proc. Natl Acad. Sci. USA 90(18), 8444-8448 (1993).
164. He X, Lehman IR: An initial ATP-independent step in the unwinding of a herpes simplex virus type I origin of replication by a complex of the viral origin-binding protein and single-strand DNA-binding protein. Proc. Natl Acad. Sci. USA 98(6), 3024-3028 (2001).
165. Reuven NB, Staire AE, Myers RS, Weller SK: The herpes simplex virus type 1 alkaline nuclease and single-stranded DNA binding protein mediate strand exchange in vitro. J. Virol. 77(13), 7425-7433 (2003). ■ Suggests a similarity between herpesvirus replication proteins and the λ RED recombination machinery.
166. Boehmer PE, Lehman IR: Herpes simplex virus type 1 ICP8: helix-destabilizing properties. J. Virol. 67(2), 711-715 (1993).
167. Bortner C, Hernandez TR, Lehman IR, Griffith J: Herpes simplex virus 1 single-strand DNA-binding protein (ICP8) will promote homologous pairing and strand transfer. J. Mol. Biol. 231(2), 241-250 (1993).
168. Dutch RE, Bruckner RC, Mocarski ES, Lehman IR: Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences. J. Virol. 66(1), 277-285 (1992).
169. Nimonkar AV, Boehmer PE: The herpes simplex virus type-1 single-strand DNA-binding protein (ICP8) promotes strand invasion. J. Biol. Chem. 278(11), 9678-9682 (2003).
170. Nimonkar AV, Boehmer PE: On the mechanism of strand assimilation by the herpes simplex virus type-1 single-strand DNA-binding protein (ICP8). Nucleic Acids Res. 31(18), 5275-5281 (2003).
171. Nimonkar AV, Boehmer PE: Reconstitution of recombination-dependent DNA synthesis in herpes simplex virus 1. Proc. Natl Acad. Sci. USA 100(18), 10201-10206 (2003).
172. Dutch RE, Lehman IR: Renaturation of complementary DNA strands by herpes simplex virus type 1 ICP8. J. Virol. 67(12), 6945-6949 (1993).
173. Tsurumi T, Kishore J, Yokoyama N et al.: Overexpression, purification and helix-destabilizing properties of Epstein-Barr virus ssDNA-binding protein. J. Gen. Virol. 79(Pt 5), 1257-1264 (1998).
174. Roizman B: The structure and isomerization of herpes simplex virus genomes. Cell 16(3), 481-494 (1979).
175. Boehmer PE, Lehman IR: Herpes simplex virus DNA replication. Annu. Rev. Biochem. 66, 347-384 (1997).
176. Boehmer PE, Nimonkar AV: Herpes virus replication. IUBMB Life 55(1), 13-22 (2003).
177. Lehman IR, Boehmer PE: Replication of herpes simplex virus DNA. J. Biol. Chem. 274(40), 28059-28062 (1999).
178. Strang BL, Stow ND: Circularization of the herpes simplex virus type 1 genome upon lytic infection. J. Virol. 79(19), 12487-12494 (2005).
179. LaFemina RL, Hayward GS: Replicative forms of human cytomegalovirus DNA with joined termini are found in permissively infected human cells but not in non-permissive Balb/c-3T3 mouse cells. J. Gen. Virol. 64(Pt 2), 373-389 (1983).
180. Marks JR, Spector DH: Fusion of the termini of the murine cytomegalovirus genome after infection. J. Virol. 52(1), 24-28 (1984).
181. McVoy MA, Adler SP: Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J. Virol. 68(2), 1040-1051 (1994).
182. Sato H, Takimoto T, Tanaka S, Tanaka J, Raab-Traub N: Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J. Virol. 64(11), 5295-5300 (1990).
183. Cho MS, Tran VM: A concatenated form of Epstein-Barr viral DNA in l ymphoblastoid cell lines induced by transfection with BZLF1. Virology 194(2), 838-842 (1993).
184. Garber DA, Beverley SM, Coen DM: Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis. Virology 197(1), 459-462 (1993).
185. Ben-Porat T, Kaplan AS, Stehn B, Rubenstein AS: Concatemeric forms of intracellular herpesvirus DNA. Virology 69(2), 547-560 (1976).
186. Severini A, Morgan AR, Tovell DR, Tyrrell DL: Study of the structure of replicative intermediates of HSV-1 DNA by pulsed-field gel electrophoresis. Virology 200(2), 428-435 (1994).
187. Jacob RJ, Morse LS, Roizman B: Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA. J. Virol. 29(2), 448-457 (1979).
188. Jongeneel CV, Bachenheimer SL: Structure of replicating herpes simplex virus DNA. J. Virol. 39(2), 656-660 (1981).
189. Ben-Porat T, Tokazewski SA: Replication of herpesvirus DNA. II. Sedimentation characteristics of newly synthesized DNA. Virology 79(2), 292-301 (1977).
190. Hirsch I, Roubal J, Vonka V: Replicating DNA of herpes simplex virus type 1. Intervirology 7(3), 155-175 (1976).
191. Poffenberger KL, Roizman B: A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection. J. Virol. 53(2), 587-595 (1985).
192. Skaliter R, Lehman IR: Rolling circle DNA replication in vitro by a complex of herpes simplex virus type 1-encoded enzymes. Proc. Natl Acad. Sci. USA 91(22), 10665-10669 (1994). ■■ Reconstitution of rolling-circle replication by herpesvirus core lytic replication proteins in vitro.
193. Skaliter R, Makhov AM, Griffith JD, Lehman IR: Rolling circle DNA replication by extracts of herpes simplex virus type 1-infected human cells. J. Virol. 70(2), 1132-1136 (1996).
194. Severini A, Scraba DG, Tyrrell DL: Branched structures in the intracellular DNA of herpes simplex virus type 1. J. Virol. 70(5), 3169-3175 (1996).
195. Jacob RJ, Roizman B: Anatomy of herpes simplex virus DNA VIII. Properties of the replicating DNA. J. Virol. 23(2), 394-411 (1977).
196. Pfuller R, Hammerschmidt W: Plasmid-like replicative intermediates of the Epstein-Barr virus lytic origin of DNA replication. J. Virol. 70(6), 3423-3431 (1996).
197. Bataille D, Epstein A: Herpes simplex virus replicative concatemers contain L components in inverted orientation. Virology 203(2), 384-388 (1994).
198. Honess RW, Buchan A, Halliburton IW, Watson DH: Recombination and linkage between structural and regulatory genes of herpes simplex virus type 1: study of the functional organization of the genome. J. Virol. 34(3), 716-742 (1980).
199. Umene K: Intermolecular recombination of the herpes simplex virus type 1 genome analysed using two strains differing in restriction enzyme cleavage sites. J. Gen. Virol. 66(Pt 12), 2659-2670 (1985).
200. Brown SM, Subak-Sharpe JH, Harland J, MacLean AR: Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease sites as unselected markers and temperature-sensitive lesions as selected markers. J. Gen. Virol. 73(Pt 2), 293-301 (1992).
201. Poffenberger KL, Tabares E, Roizman B: Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S. Proc. Natl Acad. Sci. USA 80(9), 2690-2694 (1983).
202. Jenkins FJ, Roizman B: Herpes simplex virus 1 recombinants with noninverting genomes frozen in different isomeric arrangements are capable of independent replication. J. Virol. 59(2), 494-499 (1986).
203. Mocarski ES, Roizman B: Herpesvirus-dependent amplification and inversion of cell-associated viral thymidine kinase gene flanked by viral a sequences and linked to an origin of viral DNA replication. Proc. Natl Acad. Sci. USA 79(18), 5626-5630 (1982).
204. Zimmermann J, Hammerschmidt W: Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J. Virol. 69(5), 3147-3155 (1995).
205. Dutch RE, Bianchi V, Lehman IR: Herpes simplex virus type 1 DNA replication is specifically required for high-frequency homologous recombination between repeated sequences. J. Virol. 69(5), 3084-3089 (1995).
206. Bataille D, Epstein AL: Herpes simplex virus type 1 replication and recombination. Biochimie 77(10), 787-795 (1995).
207. Weber PC, Challberg MD, Nelson NJ, Levine M, Glorioso JC: Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell 54(3), 369-381 (1988). ■■ Demonstrates the nonspecific recombination potential of herpesvirus core lytic-replication proteins.
208. Weber PC, Levine M, Glorioso JC: Recombinogenic properties of herpes simplex virus type 1 DNA sequences resident in simian virus 40 minichromosomes. J. Virol. 64(1), 300-306 (1990).
209. McVoy MA, Ramnarain D: Machinery to support genome segment inversion exists in a herpesvirus which does not naturally contain invertible elements. J. Virol. 74(10), 4882-4887 (2000).
210. Zeng Y, Middeldorp J, Madjar JJ, Ooka T: A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase. Virology 239(2), 285-295 (1997).
211. Buisson M, Geoui T, Flot D et al.: A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. J. Mol. Biol. (2009).
212. Stolzenberg MC, Ooka T: Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli. J. Virol. 64(1), 96-104 (1990).
213. Liu MT, Hu HP, Hsu TY, Chen JY: Site-directed mutagenesis in a conserved motif of Epstein-Barr virus DNase that is homologous to the catalytic centre of type II restriction endonucleases. J. Gen. Virol. 84(Pt 3), 677-686 (2003).
214. Lin SF, Hsu TY, Liu MY et al.: Characterization of Epstein-Barr virus DNase and its interaction with the major DNA binding protein. Virology 208(2), 712-722 (1995).
215. Feederle R, Bannert H, Lips H, Muller-Lantzsch N, Delecluse HJ: The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J. Virol. 83(10), 4952-4962 (2009).
216. Weitzman MD, Carson CT, Schwartz RA, Lilley CE: Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst.) 3(8-9), 1165-1173 (2004).
217. Lilley CE, Schwartz RA, Weitzman MD: Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 15(3), 119-126 (2007).
218. Wilkinson DE, Weller SK: The role of DNA recombination in herpes simplex virus DNA replication. IUBMB Life 55(8), 451-458 (2003).
219. Lilley CE, Carson CT, Muotri AR, Gage FH, Weitzman MD: DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc. Natl Acad. Sci. USA 102(16), 5844-5849 (2005).
220. Shirata N, Kudoh A, Daikoku T et al.: Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J. Biol. Chem. 280(34), 30336-30341 (2005).
221. Wilkinson DE, Weller SK: Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J. Virol. 78(9), 4783-4796 (2004). ■■ Cellular recombination/repair proteins implicated in herpesvirus replication.
222. Taylor TJ, Knipe DM: Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 78(11), 5856-5866 (2004).
223. Murata LB, Dodson MS, Hall JD: A human cellular protein activity (OF-1), which binds herpes simplex virus type 1 origin, contains the Ku70/Ku80 heterodimer. J. Virol. 78(14), 7839-7842 (2004).
224. Parkinson J, Lees-Miller SP, Everett RD: Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J. Virol. 73(1), 650-657 (1999).
225. Li H, Baskaran R, Krisky DM et al.: Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth. Virology 375(1), 13-23 (2008).
226. Wilkinson DE, Weller SK: Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection. J. Cell Sci. 119(Pt 13), 2695-2703 (2006).
227. Luo MH, Rosenke K, Czornak K, Fortunato EA: Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 81(4), 1934-1950 (2007).
228. Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA: Potential role for p53 in the permissive life cycle of human cytomegalovirus. J. Virol. 80(17), 8390-8401 (2006).
229. Kudoh A, Fujita M, Zhang L et al.: Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 280(9), 8156-8163 (2005). ■ Demonstrates that EBV activates the ATM DNA damage response pathway.
230. Kudoh A, Iwahori S, Sato Y et al.: Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments. J. Virol. 83(13), 6641-6651 (2009). ■ Demonstrates that cellular recombination proteins are recruited to EBV replication compartments.
231. Wiedmer A, Wang P, Zhou J et al.: Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication. J. Virol. 82(9), 4647-4655 (2008).
232. Bailey SG, Verrall E, Schelcher C, Rhie A, Doherty AJ, Sinclair AJ: Functional interaction between Epstein-Barr virus replication protein Zta and host DNA-damage response protein 53BP1. J. Virol. 83(21), 11116-11122 (2009).
233. Toita N, Hatano N, Ono S et al.: Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am. J. Med. Genet. A 143(7), 742-745 (2007). ■ EBV implicated as a causative agent in the formation of lymphomas in patients with DNA ligsase IV syndrome.
234. Daikoku T, Kudoh A, Sugaya Y et al.: Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments. J. Biol. Chem. 281(16), 11422-11430 (2006). ■ Demonstrates that cellular mismatch repair proteins are recruited to EBV replication compartments.
235. Wang P, Rennekamp AJ, Yuan Y, Lieberman PM: Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation. J. Virol. 83(16), 8090-8098 (2009).
236. Lu CC, Chen YC, Wang JT, Yang PW, Chen MR: Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication. J. Gen. Virol. 88(Pt 12), 3234-243 (2007).
237. Gershburg E, Raffa S, Torrisi MR, Pagano JS: Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 81(10), 5407-5412 (2007).
238. Tarakanova VL, Leung-Pineda V, Hwang S et al.: γ-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1(4), 275-286 (2007).
239. Liang X, Pickering MT, Cho NH et al.: Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 80(12), 5862-5874 (2006).
240. Paun A, Pitha PM: The IRF family, revisited. Biochimie 89(6-7), 744-753 (2007).
241. Lee HR, Toth Z, Shin YC et al.: Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J. Virol. 83(13), 6739-6747 (2009).
242. Wang Y, Li H, Tang Q, Maul GG, Yuan Y: Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J. Virol. 82(6), 2867-2882 (2008).
243. Quadt I, Gunther AK, Voss D, Schelhaas M, Knebel-Morsdorf D: TATA-binding protein and TBP-associated factors during herpes simplex virus type 1 infection: localization at viral DNA replication sites. Virus Res. 115(2), 207-213 (2006).
244. Rice SA, Long MC, Lam V, Spencer CA: RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J. Virol. 68(2), 988-1001 (1994).
245. Leopardi R, Ward PL, Ogle WO, Roizman B: Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase. J. Virol. 71(2), 1133-1139 (1997).
246. Kohzaki H, Murakami Y: Transcription factors and DNA replication origin selection. Bioessays 27(11), 1107-1116 (2005).
247. Khalil MI, Hay J, Ruyechan WT: Cellular transcription factors Sp1 and Sp3 suppress varicella-zoster virus origin-dependent DNA replication. J. Virol. 82(23), 11723-11733 (2008).
248. Lieberman PM, Hardwick JM, Hayward SD: Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions. J. Virol. 63(7), 3040-3050 (1989).
249. Hubenthal-Voss J, Starr L, Roizman B: The herpes simplex virus origins of DNA synthesis in the S component are each contained in a transcribed open reading frame. J. Virol. 61(11), 3349-3355 (1987).
250. Voss JH, Roizman B: Properties of two 5′-coterminal RNAs transcribed part way and across the S component origin of DNA synthesis of the herpes simplex virus 1 genome. Proc. Natl Acad. Sci. USA 85(22), 8454-8458 (1988).
251. Xue SA, Griffin BE: Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication. Nucleic Acids Res. 35(10), 3391-3406 (2007).
252. Lee DY, Clayton DA: Properties of a primer RNA-DNA hybrid at the mouse mitochondrial DNA leading-strand origin of replication. J. Biol. Chem. 271(39), 24262-24269 (1996).
253. Norseen J, Johnson FB, Lieberman PM: A role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 (EBNA1) in DNA replication and metaphase chromosome attachment. J. Virol. 83(20), 10336-10346 (2009).
254. Norseen J, Thomae A, Sridharan V, Aiyar A, Schepers A, Lieberman PM: RNA-dependent recruitment of the origin recognition complex. EMBO J. 27(22), 3024-3035 (2008).
255. Asai R, Kato A, Kato K et al.: Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J. Virol. 80(11), 5125-5134 (2006).
256. Wang JT, Yang PW, Lee CP, Han CH, Tsai CH, Chen MR: Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86(Pt 12), 3215-3225 (2005).
257. Kudoh A, Daikoku T, Ishimi Y et al.: Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J. Virol. 80(20), 10064-10072 (2006).
258. Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Tsurumi T: In vivo dynamics of EBNA1-OriP interaction during latent and lytic replication of Epstein-Barr virus. J. Biol. Chem. 279(52), 54817-54825 (2004).
259. Zhu J, Liao G, Shan L et al.: Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J. Virol. 83(10), 5219-5231 (2009).
260. Lu CC, Huang HT, Wang JT et al.: Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication. J. Virol. 81(3), 1195-1208 (2007).
261. Pyles RB, Thompson RL: Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J. Virol. 68(8), 4963-4972 (1994).
262. Courcelle CT, Courcelle J, Prichard MN, Mocarski ES: Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J. Virol. 75(16), 7592-7601 (2001).
263. Focher F, Verri A, Verzeletti S, Mazzarello P, Spadari S: Uracil in OriS of herpes simplex 1 alters its specific recognition by origin binding protein (OBP): does virus induced uracil-DNA glycosylase play a key role in viral reactivation and replication? Chromosoma 102(1 Suppl.), S67-S71 (1992).
264. Bogani F, Chua CN, Boehmer PE: Reconstitution of uracil DNA glycosylase-initiated base excision repair in herpes simplex virus-1. J. Biol. Chem. 284(25), 16784-16790 (2009).
265. Prichard MN, Lawlor H, Duke GM et al.: Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virol. J. 2, 55 (2005).
266. Ranneberg-Nilsen T, Dale HA, Luna L et al.: Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). J. Mol. Biol. 381(2), 276-288 (2008).